There is currently great interest in developing radiotracers to estimate cortical acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymatic activity in Alzheimer's disease patients using in vivo imaging. As part of an ongoing effort to define structure-activity relationships (SAR) for cholinesterase substrates, we have recently published in vitro and in vivo kinetic results for a series of I-["C]methyl-4-piperidinyl esters (1). These data exhibited the expected preference of AChE for short-chain esters (acetate and propionate) and the specificity of longerchain esters (butyrate and pentanoate) for BuChE. We have also shown that this general pattern of selectivity extends to the l-methylr3-pyrrolidinyl esters, la,b (2). As these latter compounds are chiral, it was of interest to extend the SAR to include the effects of stereochemistry on enzyme selectivity and cleavage rates. Irie. et al. previously reported that the AChE-mediated cleavage rates of both the acetate and propionate esters of (R)-l-methyl-3-piperidinol were much more rapid than those of the corresponding (S)-enantiomers (3). Beckett et al. have reported a similar relationship for the stereoisomers of a-and P-methylcholine esters (4,5). In our initial study, racemic mixtures of l a and l b exhibited iiz vitro AChE-mediated cleavage rates similar to the corresponding 4-piperidinyl esters, but the individual enantiomers were not tested (2). To more clearly define the structure-activity relationships for AChE and BuChE with respect to stereochemistry a to the ester functionality, we have prepared enantiomerically pure (R)-l-methyl-3-pyrrolidinyl propionate, l a and butyrate, lb, using the methods previously described for 1-methyl-4-piperidinyl propionate, PMP (6). Relative rates of substrate cleavage by purified enzymes (AChE or BuChE) were determined using a simple in vitro spectrophotometric assay (1). Esters l a and l b were also labeled with carbon-11, using methods similar to those reported for ["CIPMP (6), and the in vivo biodistribution for each in CDll mice was determined. Based on the work of Beckett et al. ( 4 3 , it would be expected that a chiral center p to the ester functionality would also influence enzymemediated cleavage rates. To address this question we have also prepared
There is currently great interest in developing radiotracers to estimate cortical acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymatic activity in Alzheimer's disease patients using in vivo imaging. As part of an ongoing effort to define structure-activity relationships (SAR) for cholinesterase substrates, we have recently published in vitro and in vivo kinetic results for a series of I-["C]methyl-4-piperidinyl esters (1). These data exhibited the expected preference of AChE for short-chain esters (acetate and propionate) and the specificity of longerchain esters (butyrate and pentanoate) for BuChE. We have also shown that this general pattern of selectivity extends to the l-methylr3-pyrrolidinyl esters, la,b (2). As these latter compounds are chiral, it was of interest to extend the SAR to include the effects of stereochemistry on enzyme selectivity and cleavage rates. Irie. et al. previously reported that the AChE-mediated cleavage rates of both the acetate and propionate esters of (R)-l-methyl-3-piperidinol were much more rapid than those of the corresponding (S)-enantiomers (3). Beckett et al. have reported a similar relationship for the stereoisomers of a-and P-methylcholine esters (4, 5) . In our initial study, racemic mixtures of l a and l b exhibited iiz vitro AChE-mediated cleavage rates similar to the corresponding 4-piperidinyl esters, but the individual enantiomers were not tested (2). To more clearly define the structure-activity relationships for AChE and BuChE with respect to stereochemistry a to the ester functionality, we have prepared enantiomerically pure (R)-l-methyl-3-pyrrolidinyl propionate, l a and butyrate, lb, using the methods previously described for 1-methyl-4-piperidinyl propionate, PMP (6) . Relative rates of substrate cleavage by purified enzymes (AChE or BuChE) were determined using a simple in vitro spectrophotometric assay (1). Esters l a and l b were also labeled with carbon-11, using methods similar to those reported for ["CIPMP (6), and the in vivo biodistribution for each in CDll mice was determined. Based on the work of Beckett et al. ( 4 3 , it would be expected that a chiral center p to the ester functionality would also influence enzymemediated cleavage rates. To address this question we have also prepared chiral esters of (S)-l-methyl-2-pyrrolidinemethanol, 2a-c, and (k)-lmethyl-2-piperidinemethano1, 334. In vitro and itz vivo investigations similar to those described above are currently underway.
The preliminary in vitro spectrophotometric data for these investigations is given in Table 1 . (R)-l-methyl-3-pyrrolidinyl propionate, @)la, is cleaved by AChE nearly three times faster than both racemic (+.)la and PMP (Table l), implying that the (S)-enantiomer of l a may act as a weak AChE inhibitor. A much less dramatic stereochemical preference was observed for the BuChE-mediated cleavage of la. This is also consistent with the in vivo distribution in mouse brain shown in Table 2 . The retention fraction for (R)la was higher than that for both PMP and (*)la in all brain areas except striatum. Similarly, the retention fractions for (R)lb were higher than those of nBMP in all brain areas.
The racemic primary ester 3b is also cleaved by AChE more rapidly than is PMP. This preference for the primary ester likely arises from the shorter amine-to-carbonyl distance in 3b, which better approximates that of acetylcholine. In contrast, (S)-l-methyl-2-pyrrolidinemethyl acetate, 23, is cleaved by AChE at a rate only 1.5 times faster than PMP and about one-third the rate of 1-methyl-4-piperidinyl acetate (AMP, MP4A).
These results indicate that AChE has a preference for the (R)-configuration at both the a-and P-positions whereas BuChE has little or no stereochemical preference. 
